<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Chemicals by </title>
      <link>https://padlet.com/yx2017be/qbayph3wcl8g</link>
      <description>Chemicals with the most favorable prices possible.</description>
      <language>en-us</language>
      <pubDate>2017-08-08 08:22:56 UTC</pubDate>
      <lastBuildDate>2019-08-21 05:58:23 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url>https://padletuploads.blob.core.windows.net/prod/80264060/cdf38ae2d21ee13c036196e76c1eb262/Backback.png</url>
      </image>
      <item>
         <title>Custom Synthesis</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/180348319</link>
         <description><![CDATA[<div>BOC Sciences’ scientists are skilled in the latest methods in synthetic organic chemistry to work closely with clients. We ensure high quality standard and on time, in full delivery. BOC Sciences has an expertise in the design and preparation of multi-step targets on scales ranging from milligrams to kilograms. Our scientists in the chemistry team are well trained to focus efforts to evaluate the synthesis. Normally, your inquiries will be addressed within 48 hours upon receipt of request. We will offer a ballpark price and a lead time for the project in a timely manner. BOC Sciences honors its quoted price even when the project might require more work than anticipated. We won't charge our clients for failed syntheses.<br><a href="http://www.bocsci.com/custom-synthesis.html">http://www.bocsci.com/custom-synthesis.html</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-08-08 08:22:56 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/180348319</guid>
      </item>
      <item>
         <title>Get quality inhibitors and APIs </title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/180348322</link>
         <description><![CDATA[<div>At BOC Sciences, you can find a wide variety of custom services which range from bulk compounds to specialty species in the pharmaceutical, agrochemical, and biotechnology industries. We are committed to providing our customers with the best products and services at the most competitive prices. Given diverse packing options for most of our chemicals, you are welcome to order the desired compounds in any quantities from a few mg to several kg along with all the relevant technical reports. We sincerely hope that our unremitting pursuits of excellence, success, and professionalism will add immense value to your research and development projects!  <a href="http://www.bocsci.com/">http://www.bocsci.com/</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-08-08 08:22:56 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/180348322</guid>
      </item>
      <item>
         <title>Antibody Drug Conjugates Services</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/180349514</link>
         <description><![CDATA[<div>BOC Sciences’ integrated capabilities for development of antibody-drug conjugates:<br><br></div><ul><li>• Analytical method: HPLC, UPLC, LCMS, UV, FL, cSDS, cIEF, CZE, DSC, TGA, ELISA, DLS, HIAC;</li><li>• Synthesis and characterization of small molecule drugs;</li><li>• Conjugated antibodies, polymers, proteins and fluorophores;</li><li>• Biotin, ADC, Polymer–drug, Polymer-drug-target ligand conjugation;</li><li>• Drug substance characterization;</li><li>• Process development;</li><li>• Technology transfer;</li><li>• Analytical method development and validation.</li><li><a href="http://www.bocsci.com/antibody-drug-conjugates-services.html">http://www.bocsci.com/antibody-drug-conjugates-services.html</a></li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2017-08-08 08:48:39 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/180349514</guid>
      </item>
      <item>
         <title>Alzheimer&#39;s disease</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/180349582</link>
         <description><![CDATA[<div>Alzheimer's disease (AD), a fatal neurodegenerative disorder, is the most common form of dementia today. It is estimated that more than 10% of people over the age of 65 are affected and, with this sector of the population increasing more rapidly than any other, So it is easy to see why developing pharmacologic treatments (medications) available for Alzheimer's disease that slows or stops the damage and destruction of neurons that cause Alzheimer's symptoms is the focus of much current research. BOC Sciences provides chemicals that can be used to cure AD. </div>]]></description>
         <enclosure url="" />
         <pubDate>2017-08-08 08:49:57 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/180349582</guid>
      </item>
      <item>
         <title>Akt inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268827802</link>
         <description><![CDATA[<div>Find it at BOC Sciences.</div>]]></description>
         <enclosure url="https://www.bocsci.com/tag/akt-51.html" />
         <pubDate>2018-06-28 06:58:55 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268827802</guid>
      </item>
      <item>
         <title>JNK Signaling Pathway</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268827883</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/jnk-signaling-pathway.html" />
         <pubDate>2018-06-28 06:59:52 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268827883</guid>
      </item>
      <item>
         <title>Hsp90 inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268827942</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/hsp90-1.html" />
         <pubDate>2018-06-28 07:00:41 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268827942</guid>
      </item>
      <item>
         <title>HDAC inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268827975</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/hdac-189.html" />
         <pubDate>2018-06-28 07:01:11 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268827975</guid>
      </item>
      <item>
         <title>organic synthesis</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268828027</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/custom-synthesis.html" />
         <pubDate>2018-06-28 07:02:10 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268828027</guid>
      </item>
      <item>
         <title>mTOR Signaling Pathway</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268828054</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/mtor-signaling-pathway.html" />
         <pubDate>2018-06-28 07:02:31 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268828054</guid>
      </item>
      <item>
         <title>Drug Discovery</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268828109</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/integrated-services-on-drug-discovery.html" />
         <pubDate>2018-06-28 07:03:18 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268828109</guid>
      </item>
      <item>
         <title>inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268828260</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/inhibitor-list-84.html" />
         <pubDate>2018-06-28 07:05:07 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/268828260</guid>
      </item>
      <item>
         <title>JNK inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708178</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/jnk-219.html" />
         <pubDate>2018-07-09 07:10:36 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708178</guid>
      </item>
      <item>
         <title>small molecule inhibitors</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708220</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/inhibitor-list-84.html" />
         <pubDate>2018-07-09 07:11:27 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708220</guid>
      </item>
      <item>
         <title>X-ray crystallography </title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708261</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/crystallization-services.html" />
         <pubDate>2018-07-09 07:11:58 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708261</guid>
      </item>
      <item>
         <title>Metabolites</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708289</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/metabolites-list-1335.html" />
         <pubDate>2018-07-09 07:12:34 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708289</guid>
      </item>
      <item>
         <title>Impurities</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708331</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/impurities-list-6.html" />
         <pubDate>2018-07-09 07:13:05 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708331</guid>
      </item>
      <item>
         <title>IDO inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708409</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/ido-6.html" />
         <pubDate>2018-07-09 07:14:31 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708409</guid>
      </item>
      <item>
         <title>mTOR Signaling Pathway</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708468</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/mtor-signaling-pathway.html" />
         <pubDate>2018-07-09 07:15:39 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708468</guid>
      </item>
      <item>
         <title>mTOR inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708506</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/mtor-252.html" />
         <pubDate>2018-07-09 07:16:24 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/269708506</guid>
      </item>
      <item>
         <title>Vitamin D2 Impurities</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843278</link>
         <description><![CDATA[<div>&nbsp;<strong>Vitamin D2 and Impurities</strong></div>]]></description>
         <enclosure url="https://www.bocsci.com/vitamin-d2-and-impurities-list-1959.html" />
         <pubDate>2018-08-18 06:05:09 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843278</guid>
      </item>
      <item>
         <title>Calcitriol Impurities</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843369</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/im-calcitriol-and-impurities-list-504.html" />
         <pubDate>2018-08-18 06:08:23 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843369</guid>
      </item>
      <item>
         <title>Calcipotriol Impurities</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843410</link>
         <description><![CDATA[<div>&nbsp;| Calcipotriol Impurities</div>]]></description>
         <enclosure url="https://www.bocsci.com/im-calcipotriol-and-impurities-list-503.html" />
         <pubDate>2018-08-18 06:09:46 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843410</guid>
      </item>
      <item>
         <title>Vitamin D Impurities</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843421</link>
         <description><![CDATA[<div> | Vitamin D Impurities</div>]]></description>
         <enclosure url="https://www.bocsci.com/vitamin-d-and-impurities-rlist-604.html" />
         <pubDate>2018-08-18 06:10:23 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843421</guid>
      </item>
      <item>
         <title>checkpoint inhibitors</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843443</link>
         <description><![CDATA[<div> | checkpoint inhibitors</div>]]></description>
         <enclosure url="https://www.bocsci.com/tag/cancer-immunotherapy-36.html" />
         <pubDate>2018-08-18 06:11:36 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843443</guid>
      </item>
      <item>
         <title>modulators</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843468</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/inhibitor-list-84.html" />
         <pubDate>2018-08-18 06:12:30 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843468</guid>
      </item>
      <item>
         <title>Formulation Service</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843507</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/formulation-service.html" />
         <pubDate>2018-08-18 06:13:32 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273843507</guid>
      </item>
      <item>
         <title>Virtual Screening</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273844428</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/virtual-screening.html" />
         <pubDate>2018-08-18 06:52:14 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/273844428</guid>
      </item>
      <item>
         <title>Dolutegravir</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296315538</link>
         <description><![CDATA[<div>Dolutegravir (GSK1349572) is a two-metal-binding HIV integrase inhibitor with IC50 of 2.7 nM, modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.https://www.bocsci.com/dolutegravir-gsk1349572-cas-1051375-16-6-item-438457.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2018-10-24 07:38:17 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296315538</guid>
      </item>
      <item>
         <title>Dolutegravir sodium</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296315782</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/dolutegravir-sodium-cas-1051375-19-9-item-84-463509.html" />
         <pubDate>2018-10-24 07:39:14 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296315782</guid>
      </item>
      <item>
         <title>Nivolumab</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296316320</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/nivolumab-cas-946414-94-4-item-470957.html" />
         <pubDate>2018-10-24 07:41:23 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296316320</guid>
      </item>
      <item>
         <title>Ursodeoxycholic Acid - CAS 128-13-2</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296316504</link>
         <description><![CDATA[<div>Ursodeoxycholic acid is a cell protectant used extensively to mitigate hepatic and biliary diseases. It may be used to study its specific activities that range from reduction of cholesterol absorption, cholesterol gallstone dissolution to suppression of immune response. https://www.bocsci.com/ursodeoxycholic-acid-cas-128-13-2-item-464698.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2018-10-24 07:42:02 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296316504</guid>
      </item>
      <item>
         <title>X-ray crystallography </title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296316825</link>
         <description><![CDATA[<div>BOC Sciences’ X-ray crystallography service utilizes its experiences and proprietary technology to assist clients in employing X-ray crystallography characterisation in their drug discovery. Our services include crystallization screening, X-ray crystallography and structure determination. In particular, BOC Sciences is expertise in co-crystallization of protein with small molecule. Please contact us for the discussion and counseling of your project.</div><div>https://www.bocsci.com/crystallization-services.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2018-10-24 07:43:21 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296316825</guid>
      </item>
      <item>
         <title>Intermediates</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296317018</link>
         <description><![CDATA[<div>A pharmaceutical intermediate is an organic compound produced during steps in the synthesis of an API that must undergo further molecular change or processing before it becomes an API. It is a “stepping stone” in the synthesis of the final product. https://www.bocsci.com/intermediates-list-52.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2018-10-24 07:44:06 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296317018</guid>
      </item>
      <item>
         <title>Tofacitinib</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296317247</link>
         <description><![CDATA[<div>Tofacitinib (CP-690550,Tasocitinib) is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States. https://www.bocsci.com/tofacitinib-cas-477600-75-2-item-84-453466.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2018-10-24 07:45:08 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296317247</guid>
      </item>
      <item>
         <title>Peficitinib</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296317450</link>
         <description><![CDATA[<div>Peficitinib, also known as ASP015K and JNJ-54781532, is a novel potent JAK inhibitor, which demonstrated potent efficacy in adjuvant-induced arthritis model in rats. ASP015K inhibited JAK1, JAK2, JAK3 and TYK2 enzyme activities with IC50 values of 3.9, 5.0, 0.71 and 4.8 nM, respectively. ASP015K inhibited the IL-2-induced proliferation of human T cells with an IC50value of 18 nM. Moreover, ASP015K was 14-fold more potent against JAK1/3 than JAK2/2 on the basis of EPO-induced proliferation of human leukemia cells. ASP015K has the potential to demonstrate JAK1/3-mediated immunomodulatory effects without the occurrence of JAK2-mediated hematopoietic effects. ASP015K may have potential use in prevention of rejection in solid organ transplantation; treatment of psoriasis; treatment of rheumatoid arthritis. https://www.bocsci.com/peficitinib-cas-944118-01-8-item-462759.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2018-10-24 07:45:58 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/296317450</guid>
      </item>
      <item>
         <title>Fluorine compounds</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352694030</link>
         <description><![CDATA[<div>BOC Sciences has major skills and a high degree of expertise in the field of fluorinated organic and inorganic chemicals, providing a creative and innovative range of building blocks, reagents and compressed and liquefied gases.  <a href="https://www.bocsci.com/fluorine-chemistry-service.html">https://www.bocsci.com/fluorine-chemistry-service.html</a></div>]]></description>
         <enclosure url="https://www.bocsci.com/fluorine-chemistry-service.html" />
         <pubDate>2019-04-19 01:16:57 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352694030</guid>
      </item>
      <item>
         <title>Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352694281</link>
         <description><![CDATA[<div> Small-molecule inhibitors are a well-established class of potential useful drugs. Our products are included in all kinds of fields of Medical and Pharmaceutical research, such as <a href="https://www.bocsci.com/tag/neurological-disease-386.html">Neurological Disease</a>, <a href="https://www.bocsci.com/tag/cancer-381.html">Cancer</a>, <a href="https://www.bocsci.com/tag/endocrinology-and-metabolic-disease-383.html">Metabolic Disease</a> and so on. https://www.bocsci.com/inhibitor-list-84.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2019-04-19 01:19:24 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352694281</guid>
      </item>
      <item>
         <title>Superparamagnetic Iron Oxide</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352694567</link>
         <description><![CDATA[<div>Superparamagnetic iron oxide microbeads have broad applications in biomedicine, such as magnetic cell isolation and biomolecules purification, magnetic resonance imaging of diseased tissues, magnetic immunoassay, targeted delivery of drugs and antigens, hyperthermia aided chemo/radiotherapy, and so on. <a href="https://www.bocsci.com/superparamagnetic-iron-oxide-nano.html">https://www.bocsci.com/superparamagnetic-iron-oxide-nano.html</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2019-04-19 01:22:04 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352694567</guid>
      </item>
      <item>
         <title>Drug design</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352694644</link>
         <description><![CDATA[<div>BOC Sciences’ capabilities in drug discovery include: computational efforts on Modeling and <a href="https://www.bocsci.com/drug-design.html">Design</a> ,Medicinal Chemistry efforts on library synthesis and SAR studies, Biological Sciences, Pharmaceutical Development, Protein Crystallography, etc.  In addition, through our intensive drug discovery knowledge and expertise in project management, we form our own integrated drug discovery platform. https://www.bocsci.com/integrated-services-on-drug-discovery.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2019-04-19 01:22:50 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352694644</guid>
      </item>
      <item>
         <title>Carbohydrate synthesis</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352694749</link>
         <description><![CDATA[<div>BOC Sciences has developed numerous multi-step synthetic schemes, like the synthesis of oligosaccharide, glycan, sugar amino acid, glycopeptide, glycoconjugate, glucuronide, glycolipid and lipopolysaccharide to provide complex chemicals. https://www.bocsci.com/carbohydrate-service.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2019-04-19 01:23:46 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352694749</guid>
      </item>
      <item>
         <title>OX40 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352694934</link>
         <description><![CDATA[<div>BOC Sciences Company is pleased to provide you with quality OX40 antibody monotherapy related services. The company has the world's leading pharmaceutical and biotechnology R &amp; D laboratory. Over the years, our experts have been working on OX 40 antibody monotherapy related techniques, and have achieved excellent results. The company sincerely looks forward to working with you hand in hand.https://www.bocsci.com/tag/ox40-also-known-as-cd134-9.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2019-04-19 01:25:31 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352694934</guid>
      </item>
      <item>
         <title>LAG3 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352695036</link>
         <description><![CDATA[<div>Lymphocyte activation gene 3（LAG-3）is an important immunosuppressive molecule, mainly expressed on the surface of activated T cells, similar to CD4 molecule structure, and highly binding to major histocompatibility complex (MHC-Ⅱ). It can negatively regulate the proliferation and function of T lymphocytes and maintain the stability of its internal environment.https://www.bocsci.com/tag/lag3-10.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2019-04-19 01:26:40 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352695036</guid>
      </item>
      <item>
         <title>B7‑H3 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352695101</link>
         <description><![CDATA[<div>B7-H3 is a type I transmembrane protein belonging to the B7 family of co-stimulatory proteins. B7-H3 is mostly expressed on professional APCs including B cells, macrophages, and dendritic cells at low levels. It is detected on various human and murine tumor cells, nasal and airway epithelial cells. Its expression on dendritic cells appears to be up-regulated by LPS. https://www.bocsci.com/tag/b7-h3-also-known-as-cd276-11.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2019-04-19 01:27:08 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/352695101</guid>
      </item>
      <item>
         <title>GPR119 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363413928</link>
         <description><![CDATA[<div>GPR119 (G protein-coupled receptor 119) is a member of the rhodopsin family of G protein-coupled receptors (GPRs). GPR119 is expressed predominantly in the pancreas and gastrointestinal tract in rodents and humans, as well as in the brain in rodents.</div>]]></description>
         <enclosure url="https://www.bocsci.com/tag/gpr119-174.html" />
         <pubDate>2019-05-25 01:56:06 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363413928</guid>
      </item>
      <item>
         <title>TIM3 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414025</link>
         <description><![CDATA[<div>cell immunoglobulin and mucin domain 3 (TIM3) is a member of Tim family, which consists of 301 amino acids. The common structure of TIM3 molecules includes: variable region of N-terminal immunoglobulin, mucin domain, transmembrane region and intracellular region. At the same time, TIM3, as an immunological checkpoint, plays an important role in the immunomodulation of tumor microenvironment. <a href="https://www.bocsci.com/tag/tim3-12.html">https://www.bocsci.com/tag/tim3-12.html</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2019-05-25 01:57:49 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414025</guid>
      </item>
      <item>
         <title>TIGIT Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414115</link>
         <description><![CDATA[<div>T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a type 1 transmembrane protein containing an IgV extracellular domain and an immunoglobulin tail tyrosine (ITT)-like phosphorylation motif followed by an immunoreceptor tyrosine-based inhibitory motif (ITIM) in the cytoplasmic tail. Similar to PD-1, TIM3, and LAG3, TIGIT is upregulated on exhausted T cells in both chronic viral infections and cancer. https://www.bocsci.com/tag/tigit-13.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2019-05-25 01:58:58 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414115</guid>
      </item>
      <item>
         <title>BTLA Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414478</link>
         <description><![CDATA[<div> It was found that the combination of high immunogenicity vaccine expressing E7 and HSV-1 glycoprotein d could block the signal transduction of BTLA-HVEM and result in strong immune activity of CD8 T cells. In addition, the combination of soluble BTLA (sBTLA) and heat shock protein 70 (HSP70) also inhibited the expression of BTLA and enhanced the immune response. sBTLA could compete with BTLA in HVEM. The HSP70 vaccine could enhance Th1 cell function and promote the secretion of cytokines IL-2 and IFN-γ. https://www.bocsci.com/tag/btla-14.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2019-05-25 02:03:27 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414478</guid>
      </item>
      <item>
         <title>VISTA Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414543</link>
         <description><![CDATA[<div>The V-domain Ig suppressor of T cell activation (VISTA) also known as PD-1 homolog (PD-1H) was described as a negative checkpoint regulator in the IgSF structurally related to CTLA-4 and PD-1. VISTA is highly expressed on tumor-infiltrating leukocytes.</div>]]></description>
         <enclosure url="https://www.bocsci.com/tag/vista-15.html" />
         <pubDate>2019-05-25 02:04:39 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414543</guid>
      </item>
      <item>
         <title>ICOS Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414597</link>
         <description><![CDATA[<div>T-cell COStimulator (ICOS) is a T cell costimulatory molecule of the CTLA4/PD1/CD28 family, and plays a nonoverlapping function with CD28 on CD4+ T cells.</div>]]></description>
         <enclosure url="https://www.bocsci.com/tag/icos-16.html" />
         <pubDate>2019-05-25 02:05:37 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414597</guid>
      </item>
      <item>
         <title>CD39 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414664</link>
         <description><![CDATA[<div>The CD39 ectonucleotidase triphosphate diphosphohydrolase 1 (Entpd1) represents a new promising target for cancer immunotherapy. CD39 is expressed on both regulatory T cells and tumor cells and plays a major role in promoting immunosuppression.</div>]]></description>
         <enclosure url="https://www.bocsci.com/tag/cd39-17.html" />
         <pubDate>2019-05-25 02:06:44 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414664</guid>
      </item>
      <item>
         <title>CD27 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414728</link>
         <description><![CDATA[<div>CD27 is a type I glycoprotein expressed on some B cells and the majority of T cells, and is a member of the tumor necrosis factor (TNF) receptor family, with unique cysteinerich motifs.</div>]]></description>
         <enclosure url="https://www.bocsci.com/tag/cd27-18.html" />
         <pubDate>2019-05-25 02:07:45 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/363414728</guid>
      </item>
      <item>
         <title>Tankyrase-1 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095461</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/tankyrase-1-427.html" />
         <pubDate>2019-06-25 10:58:01 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095461</guid>
      </item>
      <item>
         <title>Sphingosine-1-phosphate receptor 3 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095512</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/sphingosine-1-phosphate-receptor-3-s1pr3-426.html" />
         <pubDate>2019-06-25 10:58:40 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095512</guid>
      </item>
      <item>
         <title>Sphingosine-1-phosphate receptor 1 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095546</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/sphingosine-1-phosphate-receptor-1-s1pr1-425.html" />
         <pubDate>2019-06-25 10:58:56 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095546</guid>
      </item>
      <item>
         <title>Sphingosine 1 Phosphate Receptor Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095582</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/sphingosine-1-phosphate-receptor-424.html" />
         <pubDate>2019-06-25 10:59:17 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095582</guid>
      </item>
      <item>
         <title>SLC9A3 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095633</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/slc9a3-423.html" />
         <pubDate>2019-06-25 10:59:42 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095633</guid>
      </item>
      <item>
         <title></title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095659</link>
         <description><![CDATA[Selective androgen receptor modulators Inhibitor
]]></description>
         <enclosure url="https://www.bocsci.com/tag/selective-androgen-receptor-modulators-sarms-422.html" />
         <pubDate>2019-06-25 11:00:00 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095659</guid>
      </item>
      <item>
         <title>PTPN11 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095781</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/ptpn11-421.html" />
         <pubDate>2019-06-25 11:01:16 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095781</guid>
      </item>
      <item>
         <title>Prostacyclin Receptor Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095804</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/prostacyclin-receptor-420.html" />
         <pubDate>2019-06-25 11:01:37 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/369095804</guid>
      </item>
      <item>
         <title>Penicillin-binding proteins Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349571</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/penicillin-binding-proteins-417.html" />
         <pubDate>2019-07-26 03:32:46 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349571</guid>
      </item>
      <item>
         <title>Plant Growth Regulator Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349643</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/plant-growth-regulator-418.html" />
         <pubDate>2019-07-26 03:33:35 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349643</guid>
      </item>
      <item>
         <title>Potassium voltage-gated channel Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349808</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/potassium-voltage-gated-channel-kcna3-419.html" />
         <pubDate>2019-07-26 03:35:10 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349808</guid>
      </item>
      <item>
         <title>NR1D2 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349848</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/nr1d2-414.html" />
         <pubDate>2019-07-26 03:35:34 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349848</guid>
      </item>
      <item>
         <title>MTAP Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349905</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/mtap-412.html" />
         <pubDate>2019-07-26 03:36:19 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349905</guid>
      </item>
      <item>
         <title>MCH1 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349929</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/mch1-409.html" />
         <pubDate>2019-07-26 03:36:39 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349929</guid>
      </item>
      <item>
         <title>Lymphocyte function-associated antigen 1 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349952</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/lymphocyte-function-associated-antigen-1-lfa-1-408.html" />
         <pubDate>2019-07-26 03:36:57 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/372349952</guid>
      </item>
      <item>
         <title>EGFR inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375923280</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.bocsci.com/tag/egfr-140.html" />
         <pubDate>2019-08-21 05:50:25 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375923280</guid>
      </item>
      <item>
         <title>LpxC Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375923684</link>
         <description><![CDATA[<div>LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria. It is a promising target for the development of novel antibiotic substances against multigrug-resistant Gram-negative bacteria. <a href="https://www.bocsci.com/tag/lpxc-406.html">https://www.bocsci.com/tag/lpxc-406.html</a></div>]]></description>
         <enclosure url="https://www.bocsci.com/tag/lpxc-406.html" />
         <pubDate>2019-08-21 05:52:47 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375923684</guid>
      </item>
      <item>
         <title>LSD1 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375923857</link>
         <description><![CDATA[<div>Lysine-specific histone demethylase 1A (KDM1A) also known as lysine (K)-specific demethylase 1A (LSD1) is a protein in humans that is encoded by the KDM1A gene.LSD1 is a flavin-dependent monoamine oxidase, which can demethylate mono- and di-methylated lysines, specifically histone 3, lysines 4 and 9 (H3K4 and H3K9).This enzyme can have roles critical in embryogenesis and tissue-specific differentiation, as well as oocyte growth. KDM1A was the first histone demethylase to be discovered though more than 30 have been described. <a href="https://www.bocsci.com/tag/lsd1-407.html">https://www.bocsci.com/tag/lsd1-407.html</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2019-08-21 05:53:55 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375923857</guid>
      </item>
      <item>
         <title>Leucyl-tRNA synthetase Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375923952</link>
         <description><![CDATA[<div>Leucyl-tRNA synthetase, cytoplasmic is an enzyme that in humans is encoded by the LARS gene. <a href="https://www.bocsci.com/tag/leucyl-trna-synthetase-405.html">https://www.bocsci.com/tag/leucyl-trna-synthetase-405.html</a><br><br></div>]]></description>
         <pubDate>2019-08-21 05:54:28 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375923952</guid>
      </item>
      <item>
         <title>Kynurenine 3-monooxygenase Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375924054</link>
         <description><![CDATA[<div>Kynurenine 3-monooxygenase (KMO) is the expression product of the KMO (gene). It participates in tryptophan metabolism through the kynurenine catabolic pathway. It serves as an important branch point in the kynurenine pathway and, as a result, is an attractive drug target for immunological, neurodegenerative, and neuroinflammatory diseases. <a href="https://www.bocsci.com/tag/kynurenine-3-monooxygenase-kmo-404.html">https://www.bocsci.com/tag/kynurenine-3-monooxygenase-kmo-404.html</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2019-08-21 05:55:22 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375924054</guid>
      </item>
      <item>
         <title>K-Ras Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375924118</link>
         <description><![CDATA[<div>The high incidence of K-Ras mutation has been reported in pancreatic, colon, and lung carcinomas. K-Ras mutations constitute 86% of all Ras mutations and were found to be predominant in the lung, colon, pancreatic cancer and other types of cancer that account for maximal deaths in the United States. <a href="https://www.bocsci.com/tag/k-ras-403.html">https://www.bocsci.com/tag/k-ras-403.html</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2019-08-21 05:56:02 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375924118</guid>
      </item>
      <item>
         <title>DUBs Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375924177</link>
         <description><![CDATA[<div> The FDA’s approval of the inhibitors including <a href="https://www.bocsci.com/bortezomib-ps-341-cas-179324-69-7-item-293315.html">bortezomib</a> and <a href="https://www.bocsci.com/carfilzomib-cas-868540-17-4-item-305419.html">carfilzomib</a> for treatment of hematological malignancies established the UPS as an anti-cancer target. Although numerous DUB inhibitors have been reported in last decade, most of them are not pharmacologically viable in the clinic and can only be used as research tools such as Ubal (ubiquitin aldehyde) and UbVS (ubiquitin vinyl sulfone). Great efforts have been taken to design and develop UCH proteins inhibitors, which lead to identification of competitive, reversible and directed compounds of isatin O-acyl oximes series. b-AP15 is a novel proteasome-inhibitory agent that selectively inhibits the activity of two DUBs, UCHL5 and USP14. https://www.bocsci.com/tag/dubs-399.html</div>]]></description>
         <enclosure url="" />
         <pubDate>2019-08-21 05:56:39 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375924177</guid>
      </item>
      <item>
         <title>DHODH Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375924270</link>
         <description><![CDATA[<div>Dihydroorotate dehydrogenase (DHODH) is an enzyme that in humans is encoded by the DHODH gene on chromosome 16. The protein encoded by this gene catalyzes the fourth enzymatic step, the ubiquinone-mediated oxidation of dihydroorotate to orotate, in de novo pyrimidine biosynthesis. This protein is a mitochondrial protein located on the outer surface of the inner mitochondrial membrane (IMM).Inhibitors of this enzyme are used to treat autoimmune diseases such as rheumatoid arthritis. <a href="https://www.bocsci.com/tag/dhodh-398.html">https://www.bocsci.com/tag/dhodh-398.html</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2019-08-21 05:57:29 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375924270</guid>
      </item>
      <item>
         <title>Cyclin D1 Inhibitor</title>
         <author>yx2017be</author>
         <link>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375924336</link>
         <description><![CDATA[<div>Cyclin D1 (Cyclin D1) acts as a regulatory subunit of CDK4 and CDK6 (Cyclin D1/CDK4 and Cyclin D1/CDK6) and is required for G1 to S phase transition. CDK4-cyclinD1 inhibitor can inhibit DNA synthesis and cause G1 arrest. It can also block the phosphorylation of pRb protein in tumor cells, thereby inhibiting cell proliferation and anti-tumor effect.</div>]]></description>
         <enclosure url="https://www.bocsci.com/tag/cyclin-d1-397.html" />
         <pubDate>2019-08-21 05:58:02 UTC</pubDate>
         <guid>https://padlet.com/yx2017be/qbayph3wcl8g/wish/375924336</guid>
      </item>
   </channel>
</rss>
